HHL:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 8.64

Change

-0.01 (-0.12)%

Market Cap

N/A

Volume

0.12M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.51 (+1.28%)

CAD 2.91B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.94B
XHC:CA iShares Global Healthcare (CAD..

+0.13 (+0.18%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+1.24 (+2.16%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

+0.26 (+1.21%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.24 (+1.26%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.06 (+0.27%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

N/A

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.04 (+0.14%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

+0.64 (+1.02%)

CAD 0.28B

ETFs Containing HHL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.60% 34% F 39% F
Dividend Return 6.60% 100% F 96% N/A
Total Return 14.19% 66% D+ 54% F
Trailing 12 Months  
Capital Gain 11.34% 29% F 36% F
Dividend Return 9.08% 93% A 97% N/A
Total Return 20.42% 43% F 48% F
Trailing 5 Years  
Capital Gain 17.71% 29% F 49% F
Dividend Return 35.81% 100% F 96% N/A
Total Return 53.52% 46% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 2.14% N/A N/A 46% F
Dividend Return 8.83% N/A N/A 62% D
Total Return 6.69% N/A N/A 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.86% N/A N/A 55% F
Risk Adjusted Return 99.63% N/A N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike